• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Florida State Board Of Regents Florida State University; Public Coll/Univ - Unlimited Student Fees Jan 11

  • ID: 2044845
  • January 2011
  • Region: Florida
  • Standard & Poors

Standard & Poor's Ratings Services raised its ratings to 'AA' from 'AA-' on debt issued by the Florida State Board of Regents for Florida State University (FSU), including the health-fee revenue bonds and parity parking-facility bonds. The parking-facility and health-revenue bonds are viewed as equivalent to an unlimited student-fee pledge. At the same time, Standard & Poor's assigned its 'AA' long-term rating, with stable outlook, to the board's $21.3 million series 2011A parking facility revenue bonds. The university's pledge of revenues from an unlimited student health-fee charged to all students, which we view as an unlimited student fee, secures the health-revenue bonds. An unlimited student transportation-access fee charged to all students secures the parking facility bonds. The 'AA' rating reflects...

Companies mentioned in this report are:
- Florida St Univ
- Florida Board of Governors

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown

- Florida St Univ
- Florida Board of Governors

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.